US FDA announces emergency authorization for convalescent plasma to treat Covid-19

US FDA announces emergency authorization for convalescent plasma to treat Covid-19 (cnn.com)

US FDA announces emergency authorization for convalescent plasma to treat Covid-19

The US Food and Drug Administration on Sunday issued an emergency use authorization for convalescent plasma to treat Covid-19, saying the "known and potential benefits of the product outweigh the known and potential risks of the product."

The FDA said more than 70,000 patients had been treated with convalescent plasma,which is made using the blood of people who have recovered from coronavirus infections.
 
Submitted by mo2 on Thu, 07/23/2020 - 21:25